CLINICAL DEVELOPMENT IN ONCOLOGY


Crossing the Divide: A Drug Development Professional’s Experience as a Clinical Trial Participant


ROSIE FILLING, VICE PRESIDENT, SENIOR GLOBAL HEAD R&D OPERATIONS AT ENDO


Rosie’s journey reignited her passion for patient advocacy and deepened her appreciation for the vital role of clinical trial sites. Image credit: Kansuda2 Kaewwannarat via Shutterstock.com.


A


s a seasoned professional in the pharmaceutical industry, I have long been passionate about developing innovative treatments


that improve patients’ lives. However, my understanding of clinical research took on a new dimension in August 2020 when I was diagnosed with cancer and decided to participate in a clinical trial. This unexpected turn of events during the


COVID-19 crisis quickly transformed me from a drug development expert to a concerned patient navigating the complex world of healthcare. There are so many different aspects of this life-altering experience I would like to discuss. But for the purposes of this blog, I will highlight the critical importance of aligning the clinical trial technologies patients are asked to use with their actual needs, capabilities, and lifestyles.


Clinical Trials in Oncology | 37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44